EDISON LEUNG: Open Payments
NPI 1497215560 · DUBLIN, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$725 in 6 payments from 5 companies in 2025. Trend: 2023 $596 · 2024 $904 · 2025 $725
Food & beverage: $725
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 2 | $286 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $125 |
| Janssen Scientific Affairs, LLC | 1 | $114 |
| E.R. Squibb & Sons, L.L.C. | 1 | $108 |
| Neurocrine BioSciences, Inc. | 1 | $91 |
Products named: INVEGA, SPRAVATO, CAPLYTA, INVEGA SUSTENNA, COBENFY, INGREZZA.
Industry payments across CA — which companies pay providers there.
